GA + MGD meet FDA
Mar 20, 2023•49 min•Season 1Ep. 240
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Do you struggle when training eye care professionals in your office? Need to know where to turn for help? Join this week's hosts, Jimmy and Roya, as they share tips on training their staff and the programs and training modules available.
Hear about the recent FDA approval of Syfovre, the first treatment for geographic atrophy, a leading cause of blindness worldwide. In addition, they discuss the new and different treatment options for MGD.
Have an idea for a topic you would like to hear more about, or would you like to nominate or be a guest on Try Not 2 Blink? We want to hear from you! Click here to send in a suggestion, or email us at [email protected]
SOURCES
Try Not to Blink Podcast is powered by Valley Contax
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast